[Experimental allergic encephalomyelitis--clinical aspects and treatment].
D000818:Animals; D001327:Autoimmune Diseases / Q000209:etiology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003609:Dactinomycin / Q000627:therapeutic use; D004341:Drug Evaluation; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000209:etiology* / Q000628:therapy; D005620:Freund's Adjuvant / Q000627:therapeutic use; D006168:Guinea Pigs; D007111:Immunity, Cellular; D015122:Mercaptopurine / Q000627:therapeutic use; D008727:Methotrexate / Q000627:therapeutic use; D004676:Myelin Basic Protein / Q000276:immunology*; D051381:Rats; D013994:Tilorone / Q000627:therapeutic use
D004676:Myelin Basic Protein; D003609:Dactinomycin; D003520:Cyclophosphamide; D005620:Freund's Adjuvant; D015122:Mercaptopurine; D013994:Tilorone; D008727:Methotrexate
Doświadczalne alergiczne zapalenie mózgu--klinika i terapia.